Identifying potential pharmacological targets and mechanisms of vitamin D for hepatocellular carcinoma and COVID-19

Coronavirus disease 2019 (COVID‐19) is a severe pandemic that has posed an unprecedented challenge to public health worldwide. Hepatocellular carcinoma (HCC) is a common digestive system malignancy, with high aggressiveness and poor prognosis. HCC patients may be vulnerable to COVID-19. Since the an...

Descripción completa

Detalles Bibliográficos
Autores principales: Huang, Yongbiao, Yuan, Ye, Chen, Sheng, Xu, Duo, Xiao, Lingyan, Wang, Xi, Qin, Wan, Liu, Bo
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2022
Materias:
Immunology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9583923/
https://www.ncbi.nlm.nih.gov/pubmed/36275701
http://dx.doi.org/10.3389/fimmu.2022.985781

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9583923/
https://www.ncbi.nlm.nih.gov/pubmed/36275701
http://dx.doi.org/10.3389/fimmu.2022.985781

Ejemplares similares